BioLife Solutions, Inc.

Healthcare · Medical Instruments & Supplies · United States

Last price 38.61 USD (At close: Oct 5, 2026) · Market cap 1.89B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduc...